These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9222489

  • 1. Paget's disease of bone: clinical, pathogenetic and therapeutic aspects.
    Papapoulos SE.
    Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):117-43. PubMed ID: 9222489
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis and management of Paget's disease of bone.
    Ralston SH, Langston AL, Reid IR.
    Lancet; 2008 Jul 12; 372(9633):155-163. PubMed ID: 18620951
    [Abstract] [Full Text] [Related]

  • 3. Management of Paget's disease of bone.
    Langston AL, Ralston SH.
    Rheumatology (Oxford); 2004 Aug 12; 43(8):955-9. PubMed ID: 15187244
    [Abstract] [Full Text] [Related]

  • 4. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar 12; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 5. Paget's disease of bone.
    Siris ES.
    J Bone Miner Res; 1998 Jul 12; 13(7):1061-5. PubMed ID: 9661069
    [Abstract] [Full Text] [Related]

  • 6. [Therapy of Paget's disease].
    Kurth AA.
    Orthopade; 2007 Feb 12; 36(2):118, 120-3. PubMed ID: 17252256
    [Abstract] [Full Text] [Related]

  • 7. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L, Tan AJ, Del Pino-Montes J, Ralston SH.
    Cochrane Database Syst Rev; 2017 Dec 01; 12(12):CD004956. PubMed ID: 29192423
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).
    Rendina D, Falchetti A, Diacinti D, Bertoldo F, Merlotti D, Giannini S, Cianferotti L, Girasole G, Di Monaco M, Gonnelli S, Malavolta N, Minisola S, Vescini F, Rossini M, Frediani B, Chiodini I, Asciutti F, Gennari L.
    J Endocrinol Invest; 2024 Jun 01; 47(6):1335-1360. PubMed ID: 38488978
    [Abstract] [Full Text] [Related]

  • 9. Paget's disease of bone: diagnosis and treatment update.
    Noor M, Shoback D.
    Curr Rheumatol Rep; 2000 Feb 01; 2(1):67-73. PubMed ID: 11123042
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Paget's Disease of Bone with Denosumab: Case Report and Literature Review.
    Reid IR, Sharma S, Kalluru R, Eagleton C.
    Calcif Tissue Int; 2016 Sep 01; 99(3):322-5. PubMed ID: 27193832
    [Abstract] [Full Text] [Related]

  • 11. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE, Frölich M.
    J Clin Endocrinol Metab; 1996 Nov 01; 81(11):3993-7. PubMed ID: 8923849
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Stuckey BG, Lim EM, Kent GN, Ward LC, Gutteridge DH.
    J Bone Miner Res; 2001 Sep 01; 16(9):1719-23. PubMed ID: 11547843
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
    Muschitz C, Feichtinger X, Haschka J, Kocijan R.
    Wien Med Wochenschr; 2017 Feb 01; 167(1-2):18-24. PubMed ID: 27600563
    [Abstract] [Full Text] [Related]

  • 14. Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.
    Gennari C, Nuti R, Agnusdei D, Camporeale A, Martini G.
    Drug Saf; 1994 Sep 01; 11(3):179-95. PubMed ID: 7811400
    [Abstract] [Full Text] [Related]

  • 15. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES, Lyles KW, Singer FR, Meunier PJ.
    J Bone Miner Res; 2006 Dec 01; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [Abstract] [Full Text] [Related]

  • 16. Zoledronic acid for Paget's disease of bone.
    Maricic M.
    Drugs Today (Barc); 2007 Dec 01; 43(12):879-85. PubMed ID: 18174973
    [Abstract] [Full Text] [Related]

  • 17. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
    Whitson HE, Lobaugh B, Lyles KW.
    Bone; 2006 Oct 01; 39(4):954-8. PubMed ID: 16769264
    [Abstract] [Full Text] [Related]

  • 18. Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone.
    Cremers SC, Eekhoff ME, Den Hartigh J, Hamdy NA, Vermeij P, Papapoulos SE.
    J Bone Miner Res; 2003 May 01; 18(5):868-75. PubMed ID: 12733726
    [Abstract] [Full Text] [Related]

  • 19. The use of zoledronic acid for Paget's disease of bone.
    Maricic M.
    Curr Osteoporos Rep; 2006 Mar 01; 4(1):40-4. PubMed ID: 16527007
    [Abstract] [Full Text] [Related]

  • 20. Paget's Disease of Bone: Diagnosis and Treatment.
    Kravets I.
    Am J Med; 2018 Nov 01; 131(11):1298-1303. PubMed ID: 29752905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.